Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.

Lima AR, Alves FM, Angelo PF, Andrade D, Blaber SI, Blaber M, Juliano L, Juliano MA.

Biol Chem. 2008 Dec;389(12):1487-94. doi: 10.1515/BC.2008.166.

PMID:
18844446
2.

The plasma kallikrein-kinin system: its evolution from contact activation.

Schmaier AH, McCrae KR.

J Thromb Haemost. 2007 Dec;5(12):2323-9. Epub 2007 Sep 19. Review.

3.

Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.

Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, Lilla J, Nielsen BS, Christensen IJ, Craik CS, Werb Z, Danø K, Rømer J.

EMBO J. 2006 Jun 21;25(12):2686-97. Epub 2006 Jun 8.

4.

Expression of the plasma prekallikrein gene: utilization of multiple transcription start sites and alternative promoter regions.

Neth P, Arnhold M, Sidarovich V, Bhoola KD, Fink E.

Biol Chem. 2005 Feb;386(2):101-9.

PMID:
15843153
5.

Plasminogen activation and cancer.

Danø K, Behrendt N, Høyer-Hansen G, Johnsen M, Lund LR, Ploug M, Rømer J.

Thromb Haemost. 2005 Apr;93(4):676-81. Review.

PMID:
15841311
6.

The chemokine receptor D6 limits the inflammatory response in vivo.

Jamieson T, Cook DN, Nibbs RJ, Rot A, Nixon C, McLean P, Alcami A, Lira SA, Wiekowski M, Graham GJ.

Nat Immunol. 2005 Apr;6(4):403-11. Epub 2005 Mar 6.

7.

Esterase activity in leukocytes demonstrated by the use of naphthol AS-D chloroacetate substrate.

MOLONEY WC, MCPHERSON K, FLIEGELMAN L.

J Histochem Cytochem. 1960 May;8:200-7. No abstract available.

PMID:
14423467
8.

Engineering of a macromolecular scaffold to develop specific protease inhibitors.

Stoop AA, Craik CS.

Nat Biotechnol. 2003 Sep;21(9):1063-8. Epub 2003 Aug 17.

PMID:
12923547
10.

Immunolocalization of plasma kallikrein in human brain.

Cerf ME, Raidoo DM.

Metab Brain Dis. 2000 Dec;15(4):315-23.

PMID:
11383556
11.

The role of ecotin dimerization in protease inhibition.

Eggers CT, Wang SX, Fletterick RJ, Craik CS.

J Mol Biol. 2001 May 18;308(5):975-91.

PMID:
11352586
12.

Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice.

Wolters PJ, Pham CT, Muilenburg DJ, Ley TJ, Caughey GH.

J Biol Chem. 2001 May 25;276(21):18551-6. Epub 2001 Feb 23.

13.

Stromelysin-1 regulates adipogenesis during mammary gland involution.

Alexander CM, Selvarajan S, Mudgett J, Werb Z.

J Cell Biol. 2001 Feb 19;152(4):693-703.

14.

A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation.

Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z.

Nat Cell Biol. 2001 Mar;3(3):267-75.

15.

Lactational competence and involution of the mouse mammary gland require plasminogen.

Lund LR, Bjørn SF, Sternlicht MD, Nielsen BS, Solberg H, Usher PA, Osterby R, Christensen IJ, Stephens RW, Bugge TH, Danø K, Werb Z.

Development. 2000 Oct;127(20):4481-92.

16.

Activation of the plasma kallikrein/kinin system on cells: a revised hypothesis.

Schmaier AH, Røjkjaer R, Shariat-Madar Z.

Thromb Haemost. 1999 Aug;82(2):226-33. Review. No abstract available.

PMID:
10605708
17.

Activation of the plasma kallikrein/kinin system on endothelial cell membranes.

Røjkjaer R, Schmaier AH.

Immunopharmacology. 1999 Sep;43(2-3):109-14. Review.

PMID:
10596841
18.
19.

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis.

Leers MP, Kölgen W, Björklund V, Bergman T, Tribbick G, Persson B, Björklund P, Ramaekers FC, Björklund B, Nap M, Jörnvall H, Schutte B.

J Pathol. 1999 Apr;187(5):567-72.

PMID:
10398123
20.

Supplemental Content

Support Center